Earnings Feed
Start Free
MAXIM PHARMACEUTICALS INC·4

Jan 6, 7:14 PM ET

Bedard John F 4

4 · MAXIM PHARMACEUTICALS INC · Filed Jan 6, 2006

Insider Transaction Report

Form 4
Period: 2006-01-04
MAXIM PHARMACEUTICALS INCMAXM
Bedard John F
Director
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−3,125→ 0 total
    Exercise: $2.72Exp: 2014-10-04→ Common Stock (3,125 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−25,000→ 0 total
    Exercise: $1.64Exp: 2015-02-18→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−24,375→ 0 total
    Exercise: $1.64Exp: 2015-02-18→ Common Stock (24,375 underlying)
Footnotes (7)
  • [F1][Reserved]
  • [F2]The option vested 100% on date of Grant.
  • [F3]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 637 shares of EpiCept common stock for $13.34 per share.
  • [F4]The option vested 100% on 9/30/05.
  • [F5]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 5,099 shares of EpiCept common stock for $8.05 per share.
  • [F6]The option vested 100% on date of Grant.
  • [F7]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,971 shares of EpiCept common stock for $8.05 per share.

Documents

1 file
  • 4
    a4.xmlPrimary

    4